CellSource Co., Ltd. (4880.T)

JPY 636.0

(2.75%)

Market Cap (In JPY)

12.6 Billion

Revenue (In JPY)

4.51 Billion

Net Income (In JPY)

923.14 Million

Avg. Volume

55.25 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
827.0-1650.0
PE
53.22
EPS
11.95
Beta Value
0.221
ISIN
JP3423580004
CUSIP
-
CIK
-
Shares
19812220.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Masayuki Yamakawa M.D.
Employee Count
-
Website
https://www.cellsource.co.jp
Ipo Date
2019-10-29
Details
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.